IP Library Granted Patent US 11,747,266
Granted Patent B2
US 11,747,266 · App. 15/783,428 · Granted Sep 5, 2023

Systems and methods for bio-inactivation

Inventors: John Christopher Freitag (Lake Oswego, OR); Theresa Thompson (West Linn, OR); Garth Eliason (Hood River, OR); Jay Pasquantonio (Damascus, OR)
Assignee: Phoseon Technology, Inc.
G01N21/01A61L2/10B01L13/02C12M23/48B01L3/5085B01L9/523B01L2300/0829C12M37/00G01N2021/646G06K9/00127
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,747,266
App. No.
15/783,428
Granted
Sep 5, 2023
Kind
B2
Abstract

A system for irradiating a microplate may include a modular light engine with one or more light emitting devices. The light emitting devices are configured to emit germicidal radiation to irradiate the microplate, which is configured to be positioned below the modular light engine inside a chamber of the microplate irradiation system. In this way, a uniform intensity of germicidal radiation may be output by light emitting devices, resulting in disruption of contaminating nucleic acids present in the microplate.

Claims (23)

1. A method of irradiating a treatment surface with a bio-inactivation device, comprising:

activating a first light emitting device of the bio-inactivation device to emit germicidal light of a first wavelength range having a peak of 275 nm toward the treatment surface;

activating a second light emitting device of the bio-inactivation device to emit germicidal light of a second, different wavelength range having a peak of 365 nm toward one or more proteins on the treatment surface in order to deactivate the one or more proteins; and

adjusting one or more of the first light emitting device and the second light emitting device based on feedback from a photodetector of the bio-inactivation device, including:

first emitting germicidal light of the first wavelength range toward the treatment surface with the first light emitting device;

determining, based on the feedback from the photodetector, that a change in fluorescence of the treatment surface is greater than a first threshold but less than a second threshold, and in response, switching to emitting germicidal light of the second wavelength range toward the treatment surface with the second light emitting device; and

determining based on the feedback from the photodetector, that the change in fluorescence of the treatment surface is greater than the second threshold, and in response, deactivating the second light emitting device.

2. A bio-inactivation device, comprising:

a first light emitting device comprising one or more light emitting diodes configured to output light of a first wavelength of 275 nm;

a second light emitting device comprising one or more light emitting diodes configured to output light of a second wavelength of 365 nm;

a photodetector; and

a controller storing non-transitory instructions executable to:

first emit light of the first wavelength at a treatment surface with the first light emitting device;

determine, based on feedback from the photodetector, that a change in fluorescence of the treatment surface is greater than a first threshold but less than a second threshold, and in response, switch to emitting light of the second wavelength at the treatment surface with the second light emitting device; and

determine, based on the feedback from the photodetector, that the change in fluorescence of the treatment surface is greater than the second threshold, and in response deactivate the second light emitting device.

3. A bio-inactivation device, comprising:

a first light emitting device comprising one or more light emitting diodes configured to output light of a first wavelength range having a peak of 275 nm;

a second light emitting device comprising one or more light emitting diodes configured to output light of a second wavelength range having a peak of 365 nm;

a photodetector configured to detect light reflected from a treatment surface; and

a controller storing non-transitory instructions executable to:

activate the first light emitting device and the second light emitting device to emit light of the first wavelength range and the second wavelength range at the treatment surface; and

deactivate the first light emitting device and the second light emitting device responsive to an output from the photodetector indicating that an amount of light reflected from the treatment surface has changed by a threshold amount.

4. The bio-inactivation device of claim 2 , wherein the one or more light emitting diodes of the first light emitting device are configured to output light in a first range of wavelengths with a peak of 275 nm, and wherein the one or more light emitting diodes of the second light emitting device are configured to output light in a second range of wavelengths with a peak of 365 nm.

Assignments (4)
MERGER Recorded Apr 18, 2024
From: PHOSEON TECHNOLOGY, INC.
To: EXCELITAS TECHNOLOGIES CORP.
Reel/Frame 067162/0245 →
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2023
From: SILICON VALLEY BANK
To: PHOSEON TECHNOLOGY, INC.
Reel/Frame 062687/0618 →
SECURITY INTEREST Recorded Jul 23, 2020
From: PHOSEON TECHNOLOGY, INC.
To: SILICON VALLEY BANK
Reel/Frame 053293/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2017
From: FREITAG, JOHN CHRISTOPHER; THOMPSON, THERESA; ELIASON, GARTH; PASQUANTONIO, JAY
To: PHOSEON TECHNOLOGY, INC.
Reel/Frame 043861/0386 →
Continuity (2)
Provisional Application 62412030 · Oct 24, 2016
Related Publication 20180113066A1 · Apr 26, 2018